FDA Drug recall D-0150-2017
LEVOXYL(R) (levothyroxine sodium tablets, USP), 200 mcg, 100 count bottles, Rx only, Manufactured and Distributed by: King Pharmaceuticals,…
- FDA Drug
- Class II
- terminated
- Published 2016-11-30
On 2016-11-30 the FDA classified a Class II recall of LEVOXYL(R) (levothyroxine sodium tablets, USP), 200 mcg, 100 count bottles, Rx only, Manufactured and Distributed by: King Pharmaceuticals,… by Pfizer, citing superpotent.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0150-2017 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2016-11-07 |
| Published | 2016-11-30 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Pfizer |
| Distribution | US |
Product
LEVOXYL(R) (levothyroxine sodium tablets, USP), 200 mcg, 100 count bottles, Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620, NDC 60793-860-01
Reason
Superpotent
Identifiers
| ndc | 60793-850-10 |
|---|---|
| ndc | 60793-850-01 |
| ndc | 60793-851-10 |
| ndc | 60793-851-01 |
| ndc | 60793-852-10 |
| ndc | 60793-852-01 |
| ndc | 60793-853-10 |
| ndc | 60793-853-01 |
| ndc | 60793-854-10 |
| ndc | 60793-854-01 |
| ndc | 60793-855-10 |
| ndc | 60793-855-01 |
| ndc | 60793-856-10 |
| ndc | 60793-856-01 |
| ndc | 60793-857-10 |
| ndc | 60793-857-01 |
| ndc | 60793-858-10 |
| ndc | 60793-858-01 |
| ndc | 60793-859-10 |
| ndc | 60793-859-01 |
| ndc | 60793-860-10 |
| ndc | 60793-860-01 |
| code_info | 16H21, Exp. 08/2017 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Other recalls by Pfizer
- Dopamine HCl Inj., USP, 200 mg/5 mL (40 mg/mL), 5 mL Single-dose, 25 vials per tray, Rx only, Distributed by Hospira, Inc., Lake Forest, IL…
FDA Drug · Class II · 2026-09-23 · Pfizer - Vial Label: 8.4% Sodium Bicarbonate Injection, USP, 50mEq/50 mL (1 mEq/mL), Rx only, Hospira, Inc., Lake Forest, IL 60045, USA, NDC 0409-66…
FDA Drug · Class II · 2025-08-27 · Pfizer - Vial Label: Epinephrine Injection, USP, 1mg/10mL (0.1 mg/mL), Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045, USA. NDC 0409-4…
FDA Drug · Class II · 2025-08-27 · Pfizer - Levoxyl (levothyroxine sodium tablets, USP), 50 mcg, 100-count bottle, Rx only, Distributed by: Pfizer Inc., New York, NY 10017, Made in Au…
FDA Drug · Class II · 2025-08-20 · Pfizer - Bicillin L-A (penicillin G benzathine injectable suspension), 2,400,000 units per 4 mL, 4ml-vial, Rx Only, Distributed by Pfizer Inc., New…
FDA Drug · Class II · 2025-08-06 · Pfizer
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0150-2017%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.